(Q51750311)

English

The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.

scientific article published on 31 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

0 references

0 references

cannabinoid receptor

0 references

1 reference

based on heuristic

inferred from title

María Rodríguez-Muñoz

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

Javier Burgueno

4

object named as

Javier Burgueño

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

Daniel Zamanillo

5

object named as

Daniel Zamanillo

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

author name string

Pilar Sánchez-Blázquez

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

Raquel Herrero-Labrador

3

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

Javier Garzón

6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

publication date

31 January 2014

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

17

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

12

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

1943-1955

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Characterization of the cocaine binding site on the sigma-1 receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Risk for schizophrenia--broadening the concepts, pushing back the boundaries

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

What causes the onset of psychosis?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

NMDA receptors and schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Sigma receptors in schizophrenic cerebral cortices

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Involvement of direct inhibition of NMDA receptors in the effects of sigma-receptor ligands on glutamate neurotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Sigma-1 receptors: potential targets for the treatment of substance abuse

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

21 January 2018

Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000029

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145714000029

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

release_o5gv3nvozzbote3htgkwu4qoti

1 reference

https://api.fatcat.wiki/v0/release/o5gv3nvozzbote3htgkwu4qoti

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/24485144

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51750311&oldid=1989121215"